Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Ultraviolet light form emerges as a sure yet safe COVID slayer

Researchers have found a particular wavelength of UV light that can kill COVID-19 without harming people’s skin or eyes.

Panic buttons for hospital workers — passing COVID fad or new but permanent normal?

Faced with sharply spiking assault rates against nurses and other frontline healthcare workers, one U.S. medical center is equipping hundreds of its people with wearables that can summon security at the click of a button.

WHO relaunches investigation into COVID-19 origin

The World Health Organization is relaunching an investigation into the origin of the virus that causes COVID-19.

 

FDA approves Pfizer booster shot for older adults

The Food and Drug Administration has approved booster shots of the Pfizer-BioNTech COVID-19 vaccine.

 

Thumbnail

Pfizer can’t find enough pregnant women to enroll in vaccine study

Pfizer and BioNTech are having trouble finding enough participants to enroll in a study of COVID-19 vaccines in expectant mothers. 

 

COVID-19 pandemic cut life expectancy by 9M years

The COVID-19 pandemic has shaved more than nine million years off aggregate life expectancy in the U.S.

 

Thumbnail

NIH launches nationwide study on COVID-19’s long-term effects

The long-term impacts of COVID-19 infection aren’t well known, and the National Institutes of Health (NIH) plans to change that.

vaccine syringe covid-19 coronavirus

Opinions clash over COVID-19 booster shots

The Food and Drug Administration has taken a non-stance when it comes to recommending COVID-19 booster shots.

 

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.